Cargando…
PS216. Preclinical and clinical assessment of tryptophan catabolites (TRYCATS) as a measure of neuroinflammation and utility in compound screening.
Autores principales: | Allers, Kelly, Alastalo, S, Bretschneider, Tom, Hengerer, Bastian, Hoke, J, Kleiner, Oliver, Kontakanen, O, Liesener, Andre, Nold, Verena, Nurmi, A, Otto, Markus, Pleiner, S, Puolivali, J, Schoenfeldt, Carlos, Stierstorfer, Birgit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5616811/ http://dx.doi.org/10.1093/ijnp/pyw043.216 |
Ejemplares similares
-
Microbial tryptophan catabolites in health and disease
por: Roager, Henrik M., et al.
Publicado: (2018) -
Tryptophan catabolites and depression in the general population: results from the Gutenberg Health Study
por: Michal, Matthias, et al.
Publicado: (2023) -
Tracking TRYCAT: A Critical Appraisal of Kynurenine Pathway Quantifications in Blood
por: Coppens, Violette, et al.
Publicado: (2022) -
FKBP5 polymorphisms induce differential glucocorticoid responsiveness in primary CNS cells – First insights from novel humanized mice
por: Nold, Verena, et al.
Publicado: (2020) -
Tryptophan Catabolites in Bipolar Disorder: A Meta-Analysis
por: Hebbrecht, Kaat, et al.
Publicado: (2021)